These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Donor bone marrow transplantation: chimerism and tolerance. Delis S; Ciancio G; Burke GW; Garcia-Morales R; Miller J Transpl Immunol; 2004; 13(2):105-15. PubMed ID: 15380541 [TBL] [Abstract][Full Text] [Related]
3. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells. Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518 [TBL] [Abstract][Full Text] [Related]
4. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts. Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899 [TBL] [Abstract][Full Text] [Related]
5. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts. Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139 [TBL] [Abstract][Full Text] [Related]
6. Status of liver and gastrointestinal transplantation at the University of Miami. Weppler D; Khan R; Fragulidis GP; Nery JR; Ricordi C; Tzakis AG Clin Transpl; 1996; ():187-201. PubMed ID: 9286568 [TBL] [Abstract][Full Text] [Related]
7. Cardiac allograft acceptance after localized bone marrow transplantation by isolated limb perfusion in nonmyeloablated recipients. Askenasy N; Yolcu ES; Shirwan H; Wang Z; Farkas DL Stem Cells; 2003; 21(2):200-7. PubMed ID: 12634416 [TBL] [Abstract][Full Text] [Related]
8. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients. Garcia-Morales R; Carreno M; Mathew J; Cirocco R; Zucker K; Ciancio G; Burke G; Roth D; Temple D; Fuller L; Esquenazi V; Eskind L; Kenyon NS; Ricordi C; Tzakis A; Miller J Transplantation; 1998 Apr; 65(7):956-65. PubMed ID: 9565101 [TBL] [Abstract][Full Text] [Related]
9. Tolerance induction through megadose bone marrow transplantation with two-signal blockade. Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077 [TBL] [Abstract][Full Text] [Related]
10. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier. Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371 [TBL] [Abstract][Full Text] [Related]
11. The influence of donor specific vertebral body derived bone marrow cell infusion on canine islet allograft survival without irradiation conditioning of the recipient. Brendel MD; Kong SS; Schachner RD; Qian T; Selvaggi G; Alejandro R; Mintz DH; Ricordi C; Federlin K; Bretzel RG Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():129-32. PubMed ID: 8839269 [TBL] [Abstract][Full Text] [Related]
12. Correlation between allograft survival and chimeric state after bone marrow infusion in rat small bowel transplantation. Bakonyi Neto A; Ricordi C; Feo CF; Porcu A; Misiakos EP; Gandia C; Ruiz P; Bertho M; Carreno M; Esquenazi V; Miller J; Tzakis AG Pediatr Transplant; 1999 Feb; 3(1):67-73. PubMed ID: 10359034 [TBL] [Abstract][Full Text] [Related]
13. Flt-3 ligand increases microchimerism but can prevent the therapeutic effect of donor bone marrow in transiently immunosuppressed cardiac allograft recipients. Antonysamy MA; Steptoe RJ; Khanna A; Rudert WA; Subbotin VM; Thomson AW J Immunol; 1998 Apr; 160(8):4106-13. PubMed ID: 9558122 [TBL] [Abstract][Full Text] [Related]
14. The potential role of bone marrow transplantation in augmenting donor-derived immunity to hepatitis B after rat liver transplantation. Li J; Dahmen U; Dirsch OR; Gu Y; Polywka S; Fiedler M; Doebel L; Roggendorf M; Broelsch CE Liver Transpl; 2002 Apr; 8(4):397-404. PubMed ID: 11965586 [TBL] [Abstract][Full Text] [Related]
15. Donor bone marrow in laryngeal transplantation: results of a rat study. Khariwala SS; Dan O; Lorenz RR; Klimczak A; Siemionow M; Strome M Am J Otolaryngol; 2008; 29(4):242-9. PubMed ID: 18598835 [TBL] [Abstract][Full Text] [Related]
16. Infusion of nonmyeloablative bone marrow alleviates acute rejection reaction in liver allotransplantation. Xie HY; Huang DS; Jia CK; Zheng SS J Zhejiang Univ Sci B; 2005 Dec; 6(12):1188-94. PubMed ID: 16358377 [TBL] [Abstract][Full Text] [Related]
17. Allogeneic bone marrow transplantation: relation between chimaerism and immunity. Vossen J Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764 [TBL] [Abstract][Full Text] [Related]
18. The mystique of hepatic tolerogenicity. Starzl TE; Murase N; Demetris A; Trucco M; Fung J Semin Liver Dis; 2000; 20(4):497-510. PubMed ID: 11200418 [TBL] [Abstract][Full Text] [Related]
19. The beginning of clinical tolerance in solid organ allografts. Monaco AP Exp Clin Transplant; 2004 Jun; 2(1):153-61. PubMed ID: 15859922 [TBL] [Abstract][Full Text] [Related]
20. Bone marrow chimerism and tolerance induced by single-dose cyclophosphamide. Okayama J; Ko S; Kanehiro H; Kanokogi H; Hisanaga M; Ohashi K; Sho M; Nagao M; Ikeda N; Kanamura T; Akashi S; Nakajima Y J Surg Res; 2004 Jul; 120(1):102-10. PubMed ID: 15172196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]